Terazosin Hydrochloride
C
19
H
25
N
5
O
4
·HCl·2H
2
O
459.92
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride, dihydrate.
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride dihydrate
[70024-40-7] Anhydrous 423.89
[63074-08-8]
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride, dihydrate.
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride dihydrate
[70024-40-7] Anhydrous 423.89
[63074-08-8]
» Terazosin Hydrochloride contains not less than 98.0 percent and not more than 102.0 percent of C 19 H 25 N 5 O 4 ·HCl, calculated on the dried basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Terazosin Hydrochloride RSUSP Terazosin Related Compound A RS
USP Terazosin Related Compound B RS
USP Terazosin Related Compound C RS